Direct injection of vasopressin during hysteroscopic myomectomy: a case report

J Reprod Med. 2014 Nov-Dec;59(11-12):614-6.

Abstract

Background: Hysteroscopic myomectomy is the ideal procedure for symptomatic women with submucosalfibroids who desire to preserve their fertility. Vascular myomas can limit visualization when a mechanical morcellator is used. Injection of a dilute vasopressin solution has been shown to decrease blood loss during laparoscopic myomectomy. To date, direct injection of a dilute vasopressin during hysteroscopic myomectomy has not been described.

Case: Our first patient's hysteroscopic myomectomy of a vascular submucosal myoma had to be terminated before complete resection due to impaired visualization and maximum fluid overload. During a subsequent patient's procedure, direct injection ofa dilute vasopressin through the operative port decreased intraoperaftve bleeding and enabled complete resection.

Conclusion: Injecting a dilute vasopressin solution directly into a vascular submucosal myoma during hysteroscopic resection can assist with hemostasis and visualization, enabling complete resection.

Publication types

  • Case Reports

MeSH terms

  • Blood Loss, Surgical / prevention & control
  • Female
  • Hemostatics / administration & dosage*
  • Humans
  • Hysteroscopy / methods*
  • Injections, Intralesional
  • Leiomyoma / surgery*
  • Middle Aged
  • Uterine Myomectomy / methods*
  • Uterine Neoplasms / surgery*
  • Vasopressins / administration & dosage*

Substances

  • Hemostatics
  • Vasopressins